Clinical Trial Update: Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of combining pramipexole and bromocriptine with L-dopa in Parkinson disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Bromocriptine (bromocriptine)
• Pramipexole (pramipexole)
• levodopa (levodopa)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED